Home › Funds › TRAPHAGEN INVESTMENT ADVISORS LLC › CME
TRAPHAGEN INVESTMENT ADVISORS LLC position in CME
CME GROUP INC · Financials
TRAPHAGEN INVESTMENT ADVISORS LLC reported holding 48,615 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$12.7M, representing 0.87% of its reported portfolio and ranking #21 among its reported holdings. TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How TRAPHAGEN INVESTMENT ADVISORS LLC's CME position evolved
TRAPHAGEN INVESTMENT ADVISORS LLC first disclosed a stake in CME in Q3 2023 at 48,480 shares (US$9.7M). The position peaked in Q1 2026 at 48,555 shares, worth US$14.3M. Across 13 filings, TRAPHAGEN INVESTMENT ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 48,615 shares valued at US$12.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 48.48K | $9.71M | New |
| Q4 2023 | 48.48K | $10.21M | Hold |
| Q1 2024 | 48.49K | $10.44M | Hold |
| Q2 2024 | 48.49K | $9.53M | Hold |
| Q3 2024 | 48.50K | $10.70M | Hold |
| Q4 2024 | 48.50K | $11.26M | Hold |
| Q1 2025 | 48.51K | $12.87M | Hold |
| Q2 2025 | 48.52K | $13.37M | Hold |
| Q3 2025 | 48.52K | $13.11M | Hold |
| Q4 2025 | 48.54K | $13.25M | Hold |
| Q1 2026 | 48.55K | $14.34M | Hold |
| Q2 2026 | 48.59K | $10.73M | Hold |
| Q3 2026 | 48.62K | $12.74M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CME and 13F data
CME (CME GROUP INC) is a Financials company. 27 other funds we track also report a position in CME — the largest reported positions include Banque Cantonale Vaudoise (US$3.33B), Sanders Capital, LLC (US$1.12B), RAYMOND JAMES FINANCIAL INC (US$896.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CME
- Banque Cantonale Vaudoise 15.09K sh · $3.33B · Q2 2026
- Sanders Capital, LLC 5.07M sh · $1.12B · Q2 2026
- RAYMOND JAMES FINANCIAL INC 4.06M sh · $896.03M · Q2 2026
- Fidelity International (FIL) 4.00M sh · $883.86M · Q2 2026
- Alphabet Inc. 3.48M sh · $769.38M · Q2 2026
- ROYAL BANK OF CANADA 3.28M sh · $725.35M · Q2 2026
- Capital Wealth Planning, LLC 3.22M sh · $711.67M · Q2 2026
- PineStone Asset Management Inc. 2.61M sh · $683.81M · Q3 2026
More on TRAPHAGEN INVESTMENT ADVISORS LLC
FAQ
How long has TRAPHAGEN INVESTMENT ADVISORS LLC held CME?
TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is TRAPHAGEN INVESTMENT ADVISORS LLC's current position in CME?
As of Q3 2026, TRAPHAGEN INVESTMENT ADVISORS LLC holds 48.62K shares of CME (CME GROUP INC), valued at $12.74M, representing 0.87% of its reported portfolio and ranking #21.
Has TRAPHAGEN INVESTMENT ADVISORS LLC been buying or selling CME?
In the latest 13F filing (Q3 2026), TRAPHAGEN INVESTMENT ADVISORS LLC held unchanged its position in CME. The position peaked in Q1 2026 at 48.55K shares.
Which other funds hold CME?
Other major institutional holders of CME include Banque Cantonale Vaudoise, Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.